Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yael Aylon

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|November 28, 2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axisYael Aylon, Noa Furth, Giuseppe Mallel, et al.
Blood|April 15, 2018
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphomaAlexander Jethwa, Mikołaj Słabicki, Jennifer Hüllein, et al.
Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.
Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteinsSaptaparna Mukherjee, Martino Maddalena, YiQing Lü, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Nature Metabolism|June 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Cancer Cell|May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunityMengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|November 28, 2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axisYael Aylon, Noa Furth, Giuseppe Mallel, et al.
Blood|April 15, 2018
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphomaAlexander Jethwa, Mikołaj Słabicki, Jennifer Hüllein, et al.
Genes & Development|October 4, 2008
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionEfrat Shema, Itay Tirosh, Yael Aylon, et al.
Nature Communications|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patientsOri Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteinsSaptaparna Mukherjee, Martino Maddalena, YiQing Lü, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2023
p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cellsOri Hassin, Miriam Sernik, Adi Seligman, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Nature Metabolism|June 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Cancer Cell|May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunityMengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Pageof 4